Terms: = Thyroid cancer AND CDC73, HRPT2, 79577, ENSG00000134371, HPT-JT, Q6P1J9, FLJ23316, C1orf28
38 results:
1. Brown tumor due to primary hyperparathyroidism in a familial case: a case report.
Diao Z; Zhang J; Zhao J; Sun W; Pu Z
BMC Endocr Disord; 2023 Oct; 23(1):214. PubMed ID: 37807045
[TBL] [Abstract] [Full Text] [Related]
2. Approach to the Patient With Parathyroid Carcinoma.
Cetani F; Pardi E; Torregrossa L; Borsari S; Pierotti L; Dinoi E; Marcocci C
J Clin Endocrinol Metab; 2023 Dec; 109(1):256-268. PubMed ID: 37531615
[TBL] [Abstract] [Full Text] [Related]
3. Familial parathyroid tumours-comparison of clinical profiles between syndromes.
Figueiredo AA; Saramago A; Cavaco BM; Simões-Pereira J; Leite V
J Endocrinol Invest; 2023 Sep; 46(9):1799-1806. PubMed ID: 36780067
[TBL] [Abstract] [Full Text] [Related]
4. Genomic Profiling Reveals the Variant Landscape of Sporadic Parathyroid Adenomas in Chinese Population.
Tao X; Xu T; Lin X; Xu S; Fan Y; Guo B; Deng X; Jiao Q; Chen L; Wei Z; Chen C; Yang W; Zhang Z; Yu X; Yue H
J Clin Endocrinol Metab; 2023 Jun; 108(7):1768-1775. PubMed ID: 36611251
[TBL] [Abstract] [Full Text] [Related]
5. Parathyroid carcinoma during pregnancy: a novel pathogenic cdc73 mutation - a case report.
Dematapitiya C; Perera C; Pathmanathan S; Subasinghe V; Anandagoda G; Dissanayaka V; Wijenayake U; Dissanayake P; Gamage K; Wijewickrama P; Sumanatilleke M
BMC Endocr Disord; 2022 Oct; 22(1):259. PubMed ID: 36284286
[TBL] [Abstract] [Full Text] [Related]
6. Immunohistochemical Profile of Parathyroid Tumours: A Comprehensive Review.
Uljanovs R; Sinkarevs S; Strumfs B; Vidusa L; Merkurjeva K; Strumfa I
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805976
[TBL] [Abstract] [Full Text] [Related]
7. Histone Modification on Parathyroid Tumors: A Review of Epigenetics.
Conti de Freitas LC; Castilho RM; Squarize CH
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628190
[TBL] [Abstract] [Full Text] [Related]
8. Successful Control of Hypercalcemia with Sorafenib, Evocalcet, and Denosumab Combination Therapy for Recurrent Parathyroid Carcinoma.
Makino H; Notsu M; Asayama I; Otani H; Morita M; Yamamoto M; Yamauchi M; Nakao M; Miyake H; Araki A; Uchino S; Kanasaki K
Intern Med; 2022 Nov; 61(22):3383-3390. PubMed ID: 35370235
[TBL] [Abstract] [Full Text] [Related]
9. A case report of multiple endocrine neoplasia type 1 and autoimmune disease: Coincidence or correlation?
Chaves C; Nunes da Silva T; Dias Pereira B; Anselmo J; Claro I; Cavaco BM; Saramago A; Leite V
Medicine (Baltimore); 2021 Dec; 100(49):e28145. PubMed ID: 34889280
[TBL] [Abstract] [Full Text] [Related]
10. Familial Hyperparathyroidism.
Blau JE; Simonds WF
Front Endocrinol (Lausanne); 2021; 12():623667. PubMed ID: 33716975
[TBL] [Abstract] [Full Text] [Related]
11. Intratumor heterogeneity in human parathyroid tumors.
Verdelli C; Tavanti GS; Corbetta S
Histol Histopathol; 2020 Nov; 35(11):1213-1228. PubMed ID: 32468569
[TBL] [Abstract] [Full Text] [Related]
12. Late-onset postsurgical hypoparathyroidism following parathyroidectomy for recurrent primary hyperparathyroidism: a case report and literature review.
Semeraro A; Kemp EH; Pardi E; Di Certo A; Marcocci C; Cetani F
Endocrine; 2020 Aug; 69(2):402-409. PubMed ID: 32435983
[TBL] [Abstract] [Full Text] [Related]
13. Parathyroid cancer: An update.
Rodrigo JP; Hernandez-Prera JC; Randolph GW; Zafereo ME; Hartl DM; Silver CE; Suárez C; Owen RP; Bradford CR; Mäkitie AA; Shaha AR; Bishop JA; Rinaldo A; Ferlito A
Cancer Treat Rev; 2020 Jun; 86():102012. PubMed ID: 32247225
[TBL] [Abstract] [Full Text] [Related]
14. Long-Term Outcomes of Parathyroidectomy in Hyperparathyroidism-Jaw Tumor Syndrome: Analysis of Five Families with cdc73 Mutations.
Iacobone M; Camozzi V; Mian C; Pennelli G; Pagetta C; Casal Ide E; Masi G; Zovato S; Torresan F
World J Surg; 2020 Feb; 44(2):508-516. PubMed ID: 31493194
[TBL] [Abstract] [Full Text] [Related]
15. Challenges in the treatment of parathyroid carcinoma: a case report.
Russo M; Borzì G; Ilenia M; Frasca F; Malandrino P; Gullo D
Hormones (Athens); 2019 Sep; 18(3):325-328. PubMed ID: 30905030
[TBL] [Abstract] [Full Text] [Related]
16. Whole-Exome Sequencing Identifies Novel Recurrent Somatic Mutations in Sporadic Parathyroid Adenomas.
Wei Z; Sun B; Wang ZP; He JW; Fu WZ; Fan YB; Zhang ZL
Endocrinology; 2018 Aug; 159(8):3061-3068. PubMed ID: 29982334
[TBL] [Abstract] [Full Text] [Related]
17. Hyperparathyroidism-jaw Tumor Syndrome Confirmed by Preoperative Genetic Testing.
Koikawa K; Okada Y; Mori H; Kawaguchi M; Uchino S; Tanaka Y
Intern Med; 2018 Mar; 57(6):841-844. PubMed ID: 29225260
[TBL] [Abstract] [Full Text] [Related]
18. Familial Hyperparathyroidism - Disorders of Growth and Secretion in Hormone-Secretory Tissue.
Marx SJ; Lourenço DM
Horm Metab Res; 2017 Nov; 49(11):805-815. PubMed ID: 29136674
[TBL] [Abstract] [Full Text] [Related]
19. Looking beyond the thyroid: advances in the understanding of pheochromocytoma and hyperparathyroidism phenotypes in MEN2 and of non-MEN2 familial forms.
Guerin C; Romanet P; Taieb D; Brue T; Lacroix A; Sebag F; Barlier A; Castinetti F
Endocr Relat Cancer; 2018 Feb; 25(2):T15-T28. PubMed ID: 28874394
[TBL] [Abstract] [Full Text] [Related]
20. Next generation immunohistochemistry: Emerging substitutes to genetic testing?
Andrici J; Gill AJ; Hornick JL
Semin Diagn Pathol; 2018 May; 35(3):161-169. PubMed ID: 28662997
[TBL] [Abstract] [Full Text] [Related]
[Next]
